In a major breakthrough for thyroid and breast cancer care, Huashan Hospital of Fudan University successfully completed Shanghai's first single-port robotic breast cancer mastectomy with immediate reconstruction and the city’s first robotic thyroidectomy using the SHURUI® system.
Led by Prof. Qiang Zou and Prof. Yiting Jin, the surgical team utilized SHURUI®'s flexible snake-like instruments and 3D imaging to perform both complex procedures through a single hidden incision—preserving aesthetics while ensuring oncologic precision. For the breast case, gland removal and reconstruction were completed without visible scarring. In the thyroid case, a subclavicular approach avoided neck incisions altogether.
With over 40 years of experience in breast and endocrine surgery, Huashan Hospital’s innovation reflects a shift toward ultra-minimally invasive, patient-centered solutions. As SHURUI® single-port robotics expands in China, Huashan is advancing individualized, scar-concealed treatment for head, neck, and chest cancers.
The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.
Safety and Performance Information
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.